SCPH: יעד קונצנזוס scPharma

scPharmaceuticals Inc. (SCPH) is currently launching its primary cardiology product, with distribution costs temporarily exceeding profits, which fixes the indicator at 7.81. The business relies on the development of advanced wearable pumps and liquid formulations for outpatient treatment. This price chart on GURU.Markets complements data regarding the importance of strict logistics when transporting such specific subcutaneous agents.

This indicator captures the trend of the average target share price, consolidating daily valuation revisions from investment banks into a single line to identify shifts in market consensus. By analyzing the weighted consensus target for the stock, an investor can assess how the production robotization and automation of cartridge filling lines at scPharmaceuticals Inc. (SCPH) are reflected in the professional analysts' revaluation of the business's fair value.